Two Sigma Investments, LP Vista Gen Therapeutics, Inc. Transaction History

Two Sigma Investments, LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.12 - $0.3 $39,562 - $98,907	-329,690 Reduced 49.88%	331,287 $39,000
Q4 2022 Feb 14, 2023	SELL	$0.09 - $4.8 $16,660 - $888,580	-185,121 Reduced 21.88%	660,977 $66,000
Q3 2022 Nov 14, 2022	BUY	$0.14 - $4.8 $110,984 - $3.81 Million	792,749 Added 1485.97%	846,098 $129,000
Q2 2022 Aug 15, 2022	SELL	$0.88 - $1.73 $293,262 - $576,527	-333,253 Reduced 86.2%	53,349 $47,000
Q1 2022 May 16, 2022	SELL	$1.14 - $2.09 $97,021 - $177,873	-85,107 Reduced 18.04%	386,602 $479,000
Q4 2021 Feb 14, 2022	SELL	$1.67 - $2.76 $1.08 Million - $1.79 Million	-646,975 Reduced 57.83%	471,709 $920,000
Q3 2021 Nov 15, 2021	SELL	$2.62 - $3.45 $184,544 - $243,007	-70,437 Reduced 5.92%	1,118,684 $3.07 Million
Q2 2021 Aug 16, 2021	BUY	$1.96 - $3.15 $492,283 - $791,169	251,165 Added 26.78%	1,189,121 $3.75 Million
Q1 2021 May 17, 2021	BUY	$1.89 - $2.96 $1.51 Million - $2.36 Million	796,458 Added 562.88%	937,956 $2 Million
Q4 2020 Feb 16, 2021	BUY	$0.65 - $1.94 $79,560 - $237,456	122,400 Added 640.9%	141,498 $275,000
Q3 2020 Nov 16, 2020	BUY	$0.48 - $1.03 $9,167 - $19,670	19,098 New	19,098 $13,000

2.7M

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $610M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.